IP Library Assignment 036054/0740
Patent Assignment
Reel/Frame 036054/0740

Corrective Assignment to Correct the Receiving Party Information Previously Recorded on Reel 035920 Frame 0576. Assignor(S) Hereby Confirms the Receiving Party Name Should Be Recorded as Two Parties.

Recorded: 2015-07-02 Pages: 22
Assignor
INCYTE CORPORATION
Executed: 2015-01-07
Assignees
INCYTE HOLDINGS CORPORATION
1801 AUGUSTINE CUT-OFF, WILMINGTON, DELAWARE, 19803
INCYTE CORPORATION
1801 AUGUSTINE CUT-OFF, WILMINGTON, DELAWARE, 19803
Covered Properties (110)
3-Aminopyrrolidine Derivaties as Modulators of Chemokine Receptors
Patent: 7,834,021 →
Application: 10/535,795 →
Publication: US 2006/0252751
Piperazinylpiperidine Derivatives as Chemokine Receptor Antagonists
Patent: 7,678,798 →
Application: 11/104,041 →
Publication: US 2005/0261310
Amido Compounds and Their Use as Pharmaceuticals
Patent: 7,304,081 →
Application: 11/122,309 →
Publication: US 2005/0282858
3-(4-Heteroarylcyclohexylamino)Cyclopentanecarboxamides as Modulators of Chemokine Receptors
Patent: 7,307,086 →
Application: 11/125,647 →
Publication: US 2005/0267146
N-Substituted Piperidines and Their Use as Pharmaceuticals
Patent: 8,071,624 →
Application: 11/159,448 →
Publication: US 2006/0004049
2-Methylprop Anamides and Their Use as Pharmaceuticals
Patent: 7,687,665 →
Application: 11/159,865 →
Publication: US 2005/0288329
3-Aminocyclopentanecarboxamides as Modulators of Chemokine Receptors
Patent: 7,618,970 →
Application: 11/167,329 →
Publication: US 2006/0020133
3-Aminocyclopentanecarboxamides as Modulators of Chemokine Receptors
Patent: 7,449,467 →
Application: 11/167,816 →
Publication: US 2006/0004018
Modulators of Indoleamine 2,3-Dioxygenase and Methods of Using the Same
Patent: 8,034,953 →
Application: 11/430,441 →
Publication: US 2006/0258719
3-Aminocyclopentanecarboxamides as Modulators of Chemokine Receptors
Patent: 7,700,624 →
Application: 11/613,330 →
Publication: US 2007/0149532
Lactam Compounds and Methods of Using the Same
Patent: 8,193,207 →
Application: 11/633,347 →
Publication: US 2007/0129345
N-Hydroxyamidinoheterocycles as Modulators of Indoleamine 2,3-Dioxygenase
Patent: 8,450,351 →
Application: 11/641,284 →
Publication: US 2007/0185165
Modulators of 11-Beta Hydroxyl Steroid Dehydrogenase Type 1, Pharmaceutical Compositions Thereof, and Methods of Using the Same
Patent: 7,998,959 →
Application: 11/652,191 →
Publication: US 2007/0197506
Heterocyclic Inhibitors of 11-Beta Hydroxyl Steroid Dehydrogenase Type 1 and Methods of Using the Same
Patent: 7,838,544 →
Application: 11/803,808 →
Publication: US 2007/0270424
Triazolotriazines as Kinase Inhibitors
Patent: 7,683,060 →
Application: 11/834,226 →
Publication: US 2008/0039457
Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors
Patent: 7,767,675 →
Application: 11/942,130 →
Publication: US 2008/0167287
Amido Compounds and Their Use as Pharmaceuticals
Patent: 7,776,874 →
Application: 12/136,529 →
Publication: US 2008/0255154
Spirocycles as Inhibitors of 11-Beta Hydroxyl Steroid Dehydrogenase Type 1
Patent: 8,278,318 →
Application: 12/143,427 →
Publication: US 2008/0318991
3-Aminocyclopentanecarboxamides as Modulators of Chemokine Receptors
Patent: 8,470,827 →
Application: 12/238,121 →
Publication: US 2010/0119503
Lactam Compounds and Their Use as Pharmaceuticals
Patent: 8,110,581 →
Application: 12/252,700 →
Publication: US 2009/0291946
Piperazinylpiperidine Derivatives as Chemokine Receptor Antagonists
Patent: 8,268,826 →
Application: 12/422,517 →
Publication: US 2009/0197887
3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
Patent: 7,985,730 →
Application: 12/430,446 →
Publication: US 2009/0247474
3-Aminocyclopentanecarboxamides as Modulators of Chemokine Receptors
Patent: 8,563,582 →
Application: 12/432,040 →
Publication: US 2009/0208485
Salts of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Yl-Methyl)-Imidazo[1,2-B][1,2,4]Triazin-2-Yl]Benzamide and Processes Related to Preparing the Same
Patent: 8,420,645 →
Application: 12/469,360 →
Publication: US 2009/0291956
1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
Patent: 8,088,803 →
Application: 12/498,782 →
Publication: US 2010/0015178
Triazolotriazines as Kinase Inhibitors
Patent: 7,915,408 →
Application: 12/695,636 →
Publication: US 2010/0130467
Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors
Patent: 8,461,330 →
Application: 12/813,148 →
Publication: US 2011/0136781
Amido Compounds and Their Use as Pharmaceuticals
Patent: 8,058,288 →
Application: 12/817,887 →
Publication: US 2010/0256114
Imidazo[1,2-B][1,2,4]Triazines as C-Met Inhibitors
Patent: 8,487,096 →
Application: 13/019,718 →
Publication: US 2011/0212967
Triazolotriazines as Kinase Inhibitors
Patent: 8,143,251 →
Application: 13/033,918 →
Publication: US 2011/0144113
N-Hydroxyamidinoheterocycles as Modulators of Indoleamine 2,3-Dioxygenase
Patent: 8,507,541 →
Application: 13/050,143 →
Publication: US 2011/0165188
N-Hydroxyamidinoheterocycles as Modulators of Indoleamine 2,3-Dioxygenase
Patent: 8,377,976 →
Application: 13/070,069 →
Publication: US 2011/0172279
3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
Patent: 8,362,003 →
Application: 13/162,286 →
Publication: US 2011/0251168
Modulators of Indoleamine 2,3-Dioxygenase and Methods of Using the Same for Treating Cancer
Patent: 8,372,870 →
Application: 13/220,406 →
Publication: US 2011/0311479
Amido Compounds And Their Use As Pharmaceuticals
Patent: 9,126,927 →
Application: 13/243,565 →
Publication: US 2012/0015928
N-Substituted Piperidines and Their Use as Pharmaceuticals
Patent: 8,288,417 →
Application: 13/279,700 →
Publication: US 2012/0040964
1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
Patent: 8,796,319 →
Application: 13/294,711 →
Publication: US 2012/0058079
Substituted Imidazopyridazines and Benzimidazoles as Inhibitors of FGFR3
Patent: 8,754,114 →
Application: 13/333,021 →
Publication: US 2012/0165305
Lactam Compounds and Their Use as Pharmaceuticals
Patent: 8,563,570 →
Application: 13/355,219 →
Publication: US 2012/0122858
Piperazinylpiperidine Derivatives as Chemokine Receptor Antagonists
Patent: 8,680,104 →
Application: 13/564,434 →
Publication: US 2012/0295912
Spirocycles as Inhibitors of 11-Beta Hydroxyl Steroid Dehydrogenase Type 1
Patent: 9,006,260 →
Application: 13/619,160 →
Publication: US 2013/0018068
Isoindolinone and Pyrrolopyridinone Derivatives as Akt Inhibitors
Patent: 8,895,571 →
Application: 13/650,373 →
Publication: US 2013/0096144
3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
Patent: 8,729,063 →
Application: 13/722,740 →
Publication: US 2013/0116230
Modulators of Indoleamine 2,3-Dioxygenase and Methods of Using the Same
Patent: 8,846,726 →
Application: 13/734,263 →
Publication: US 2013/0123246
N-Hydroxyamidinoheterocycles as Modulators of Indoleamine 2,3-Dioxygenase
Patent: 8,951,536 →
Application: 13/780,510 →
Publication: US 2013/0177590
Salts of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Yl-Methyl)-Imidazo[1,2-B][1,2,4]Triazin-2-Yl]Benzamide and Processes Related to Preparing the Same
Patent: 8,901,123 →
Application: 13/793,864 →
Publication: US 2013/0289036
Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors
Application: 13/895,799 →
Publication: US 2013/0324515
Imidazo[1,2-B][1,2,4]Triazines as C-Met Inhibitors
Patent: 9,221,824 →
Application: 13/915,702 →
Publication: US 2013/0345224
Substituted Tricyclic Compounds as Fgfr Inhibitors
Patent: 9,611,267 →
Application: 13/915,775 →
Publication: US 2013/0338134
SUBSTITUTED PYRROLO[2,3-b]PYRAZINES AS FGFR INHIBITORS
Patent: 9,388,185 →
Application: 13/963,569 →
Publication: US 2014/0045814
1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
Patent: 8,822,511 →
Application: 14/033,117 →
Publication: US 2014/0023663
Fused Pyrazoles as FGFR Inhibitors
Patent: 9,266,892 →
Application: 14/132,653 →
Publication: US 2014/0171405
Piperazinylpiperidine Derivatives as Chemokine Receptor Antagonists
Patent: 9,067,921 →
Application: 14/176,781 →
Publication: US 2014/0155404
Tricyclic Heterocycles as Bet Protein Inhibitors
Patent: 9,227,985 →
Application: 14/212,721 →
Publication: US 2014/0275030
Bicyclic Heterocycles as Fgfr Inhibitors
Patent: 9,533,984 →
Application: 14/256,438 →
Publication: US 2014/0315902
Substituted Imidazopyridazines and Benzimidazoles as Inhibitors of FGFR3
Patent: 9,533,954 →
Application: 14/267,139 →
Publication: US 2014/0243308
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
Patent: 8,993,605 →
Application: 14/322,362 →
Publication: US 2014/0315962
Tricyclic Heterocycles as Bet Protein Inhibitors
Patent: 9,290,514 →
Application: 14/324,560 →
Publication: US 2015/0011540
Modulators of Indoleamine 2,3-Dioxygenase and Methods of Using the Same
Application: 14/478,622 →
Publication: US 2014/0377292
Salts of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Yl-Methyl)- Imidazo[1,2-B][1,2,4]Triazin-2-Yl]Benzamide and Processes Related to Preparing the Same
Application: 14/525,381 →
Publication: US 2015/0148348
Process for the Synthesis of an Indoleamine 2,3-Dioxygenase Inhibitor
Patent: 9,321,755 →
Application: 14/535,781 →
Publication: US 2015/0133674
3,4-Disubstituted pyrrolidine derivatives as modulators of chemokine receptors
Application: 60/429,605 →
3-Aminopyrrolidine derivatives as modulators of chemokine receptors
Application: 60/463,976 →
Piperazinylpiperidine derivatives as cytokine receptor antagonists
Application: 60/561,697 →
Inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 and methods of using the same
Application: 60/569,273 →
3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
Application: 60/569,947 →
Piperazinylpiperidine derivatives as cytokine receptor antagonists
Application: 60/572,221 →
Inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 and methods of using the same
Application: 60/582,477 →
Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/582,557 →
Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/602,051 →
Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/602,791 →
Inhibitors fo 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/614,570 →
3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
Application: 60/624,374 →
3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
Application: 60/624,481 →
Inhibitors of 11-B hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/626,617 →
Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/638,803 →
Modulators of indoleamine 2,3-dioxygenase and methods of using the same
Application: 60/679,507 →
N-substituted piperidines and their use as pharmaceuticals
Application: 60/686,840 →
Lactam compounds and their use as pharmaceuticals
Application: 60/715,020 →
Lactam compounds and methods of using the same
Application: 60/742,353 →
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
Application: 60/751,854 →
3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
Application: 60/752,477 →
Modulators of 11-¿ hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
Application: 60/758,352 →
Heterocyclic inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/801,326 →
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
Application: 60/801,337 →
Lactam compounds and methods of using the same
Application: 60/808,678 →
Heterocyclic inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
Application: 60/808,703 →
Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
Application: 60/808,884 →
Triazolotriazines as kinase inhibitors
Application: 60/835,942 →
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
Application: 60/845,700 →
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3- dioxygenase
Application: 60/845,711 →
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
Application: 60/857,558 →
Imidazotriazines and imidazopyrimidines as kinase inhibitors
Application: 60/860,840 →
Imidazotriazines and imidazopyrimidines as kinase inhibitors
Application: 60/861,459 →
Triazolotriazines as kinase inhibitors
Application: 60/861,931 →
Spirocycles as Inhibitors of 11-Beta Hydroxyl Steroid Dehydrogenase Type 1
Application: 60/945,487 →
Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors
Application: 60/957,236 →
SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-2-YL]BENZAMIDE
Application: 61/054,995 →
IMIDAZO[1,2-b][1,2,4]TRIAZINES AS C-MET INHIBITORS
Application: 61/300,946 →
Substituted Imidazopyridazines and Benzimidazoles as Inhibitors of FGFR3
Application: 61/426,273 →
Isoindolinone and Pyrrolopyridinone Derivatives as Akt Inhibitors
Application: 61/547,293 →
Substituted Tricyclic Compounds as Fgfr Inhibitors
Application: 61/659,245 →
Pyrazine Derivatives as Fgfr Inhibitors
Application: 61/682,103 →
Substituted Tricyclic Compounds as Fgfr Inhibitors
Application: 61/691,463 →
Fused Pyrazoles as FGFR Inhibitors
Application: 61/739,374 →
Substituted Tricyclic Compounds as Fgfr Inhibitors
Application: 61/740,012 →
Substituted Tricyclic Compounds as Fgfr Inhibitors
Application: 61/774,841 →
Tricyclic Heterocycles as Bet Protein Inhibitors
Application: 61/794,812 →
Bicyclic Heterocycles as Fgfr Inhibitors
Application: 61/813,782 →
Tricyclic Heterocycles as Bet Protein Inhibitors
Application: 61/843,638 →
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 3, 2005
From: XUE, CHU-BIAO; CAO, GANFENG; HUANG, TAISHENG; CHEN, LIHUA
To: INCYTE CORPORATION
Reel/Frame 016608/0597 →
Assignment of Assignor's Interest Aug 4, 2005
From: XUE, CHU-BIAO; ZHENG, CHANGSHENG; CAO, GANFENG; FENG, HAO
To: INCYTE CORPORATION
Reel/Frame 016611/0393 →
Assignment of Assignor's Interest Aug 30, 2005
From: YAO, WENQING; ZHUO, JINCONG; XU, MEIZHONG; METCALF, BRIAN W.
To: INCYTE CORPORATION
Reel/Frame 016683/0729 →
Assignment of Assignor's Interest Sep 8, 2005
From: YAO, WENQING; ZHANG, COLIN; HE, CHUNHONG; ZHUO, JINCONG
To: INCYTE CORPORATION
Reel/Frame 016752/0791 →
Assignment of Assignor's Interest Oct 6, 2005
From: XUE, CHU-BIAO; ZHENG, CHANGSHENG; FENG, HAO; XIA, MICHAEL
To: INCYTE CORPORATION
Reel/Frame 016854/0496 →
Security Agreement Nov 30, 2005
From: INCYTE CORPORATION
To: PFIZER INC.
Reel/Frame 017281/0496 →
Assignment of Assignor's Interest Dec 20, 2005
From: XUE, CHU-BIAO; ZHENG, CHANGSHENG; FENG, HAO; XIA, MICHAEL
To: INCYTE CORPORATION
Reel/Frame 017646/0134 →
Document Previously Recorded at Reel 016854 Frame 0496 Contained Errors in Patent Application Number 11/167,328. Document Rerecorded to Correct Errors on Stated Reel. Dec 20, 2005
From: XUE, CHU-BIAO; ZHENG, CHANGSHENG; FENG, HAO; XIA, MICHAEL
To: INCYTE CORPORATION
Reel/Frame 017134/0689 →
Assignment of Assignor's Interest Dec 28, 2005
From: YAO, WENQING; XU, MEIZHONG; ZHANG, COLIN; LI, YANLONG
To: INCYTE CORPORATION
Reel/Frame 017150/0199 →
Assignment of Assignor's Interest Mar 20, 2006
From: XUE, CHU-BIAO; FENG, HAO; HUANG, TAISHENG; METCALF, BRIAN W.
To: INCYTE CORPORATION
Reel/Frame 017351/0168 →
Confirmatory License Mar 20, 2006
From: INCYTE CORPORATION
To: PFIZER INC.
Reel/Frame 017351/0136 →
Assignment of Assignor's Interest Jul 7, 2006
From: COMBS, ANDREW P.; YUE, EDDY W.
To: INCYTE CORPORATION
Reel/Frame 017907/0547 →
Assignment of Assignor's Interest Feb 7, 2007
From: ZHUO, JINCONG; QIAN, DING-QUAN; YAO, WENQING
To: INCYTE CORPORATION
Reel/Frame 018867/0604 →
Assignment of Assignor's Interest Mar 22, 2007
From: XUE, CHU-BIAO
To: INCYTE CORPORATION
Reel/Frame 019061/0489 →
Assignment of Assignor's Interest Apr 20, 2007
From: COMBS, ANDREW P.; TAKVORIAN, AMY; ZHU, WENYU; SPARKS, RICHARD B.
To: INCYTE CORPORATION
Reel/Frame 019199/0006 →
Assignment of Assignor's Interest May 11, 2007
From: YAO, WENQING; BURNS, DAVID M.; CHEN, LIHUA; ZHUO, JINCONG
To: INCYTE CORPORATION
Reel/Frame 019281/0173 →
Assignment of Assignor's Interest Jul 12, 2007
From: LI, YUN-LONG; ZHUO, JINCONG; YAO, WENQING
To: INCYTE CORPORATION
Reel/Frame 019555/0538 →
Assignment of Assignor's Interest Mar 11, 2008
From: ZHUO, JINCONG; XU, MEIZHONG; HE, CHUNHONG; ZHANG, COLIN
To: INCYTE CORPORATION
Reel/Frame 020633/0897 →
Assignment of Assignor's Interest Apr 16, 2008
From: ZHUO, JINCONG; ZHANG, COLIN; XU, MEIZHONG; QIAN, DING-QUAN
To: INCYTE CORPORATION
Reel/Frame 020816/0449 →
Assignment of Assignor's Interest Dec 15, 2008
From: YAO, WENQING; ZHUO, JINCONG; XU, MEIZHONG; ZHANG, COLIN
To: INCYTE CORPORATION
Reel/Frame 021982/0801 →
Assignment of Assignor's Interest May 12, 2009
From: XU, MEIZHONG; AGRIOS, KONSTANTINOS; METCALF, BRIAN
To: INCYTE CORPORATION
Reel/Frame 022675/0132 →
Assignment of Assignor's Interest Jun 16, 2015
From: INCYTE CORPORATION
To: INCYTE HOLDINGS CORPORATION AND INCYTE CORPORATION
Reel/Frame 035920/0576 →